SAN ANTONIO — Cutaquig provided safe and effective dosing flexibility for patients with primary immunodeficiency disease, according to data presented at the American Academy of Allergy, Asthma & ...
BACKGROUND: Current prescribing information recommends that physicians apply a dose ratio of 1.37:1 (1.53:1 prior to January 2015) in the United States (US) when switching patients with primary ...
November 21, 2011 (Boston, Massachusetts) — A novel immunoglobulin (Ig)G replacement therapy that uses hyaluronidase to facilitate dosing with gammaglobulin has shown good efficacy in preventing ...
Xembify (immune globulin subcutaneous, human- klhw), a 20% immune globulin solution has been made available by Grifols. Xembify (immune globulin subcutaneous, human- klhw), a 20% immune globulin ...
Panelists discuss how challenges such as extended nursing workflow, patient hesitancy, limited formulation indications, reimbursement complexities, and insufficient economic incentives slow the ...
March 22, 2004 (San Francisco) — Antibody-deficient patients are able to safely tolerate subcutaneous delivery of immunoglobulin G (IgG), researchers reported here Saturday at the annual meeting of ...
Intravenous immunoglobulin (IVIg) treatment can help you fight off infections if you have a weakened immune system or other diseases. Some people may have IVIg instead of other medications (such as ...
DALLAS--(BUSINESS WIRE)--Advanced Infusion Care (AIC), a division of AIS Healthcare, today announced a recent feature in the National Home Infusion Association’s (NHIA) Infusion Journal. The case ...
Intravenous immunoglobulin (IVIG) therapy involves infusing patients with naturally occurring IgG antibodies to treat ...
Some IVIG brands, like Gammagard, contain added sugar. This could cause your blood glucose to rise temporarily. But studies don’t show weight gain as a typical side effect of IVIG. Intravenous ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback